BRIEF-Shanghai Fosun Pharmaceutical responds to media reports

March 30 (Reuters) - Shanghai Fosun Pharmaceutical Group Co


* Reference is made to announcements of Shanghai Fosun

Pharmaceutical (Group) Co., dated 28 July 2016

* Recently, there have been media reports provide that

acquisition was approved by relevant competent authorities of


* Acquisition was approved by shareholders at 2016 third

extraordinary general meeting of company

* Relevant approvals of competent authorities of PRC in

relation to acquisition have been obtained

* Acquisition was reviewed by Indian foreign investment

promotion board

* Filings with competent antitrust authorities of united

states have been completed

* Acquisition will be recommended to cabinet committee on

economic affairs of India for further review and approval

Source text for Eikon:

Further company coverage: